comparemela.com
Home
Live Updates
Licensing agreement after osteoarthritis drug shows positive results : comparemela.com
Licensing agreement after osteoarthritis drug shows positive results
Pennsylvania-based Levolta Pharmaceuticals has entered into an exclusive licensing and distribution agreement with Saudi Arabia company, Tabuk Pharmaceutical Manufacturing Company to start commercializing a therapy for osteoarthritis (OA).
Related Keywords
United States
,
Saudi Arabia
,
South Africa
,
Tabuk
,
Richard Becker
,
Mohammed Al Hagbani
,
Ketan Desai
,
National Institute On
,
Council For Disability Awareness
,
Astra Industrial Group
,
Tabuk Pharmaceuticals
,
Middle East
,
National Institute
,
Markets Amp Regulations
,
Osteoarthritis
,
Therapy
,
Clinical Trial
,
Licensing Agreement
,
Pharmaceutical Industry
,
comparemela.com © 2020. All Rights Reserved.